A larval zebrafish model of cardiac physiological recovery following cardiac arrest and myocardial hypoxic damage

• Warren Burggren,
• Regina Abramova,
• Naim M. Bautista,
• Regina Fritsche Danielson,
• Ben Dubansky,
• Avi Gupta,
• Kenny Hansson,
• Neha Iyer,
• Pudur Jagadeeswaran,
• Karin Jennbacken,
• Katarina Rydén-Markinhutha,
• Vishal Patel,
• Revathi Raman,
• Hersh Trivedi,
• Karem Vazquez Roman,
• Steven Williams,
• Qing-Dong Wang

Affiliations

Warren Burggren

Developmental Integrative Biology Research Group, Department of Biological Sciences, University of North Texas, Denton, TX 76205, USA

Regina Abramova

Developmental Integrative Biology Research Group, Department of Biological Sciences, University of North Texas, Denton, TX 76205, USA

Naim M. Bautista

Developmental Integrative Biology Research Group, Department of Biological Sciences, University of North Texas, Denton, TX 76205, USA

Regina Fritsche Danielson

SVP and head of Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg 431 50, Sweden

Ben Dubansky

Developmental Integrative Biology Research Group, Department of Biological Sciences, University of North Texas, Denton, TX 76205, USA

Avi Gupta

Developmental Integrative Biology Research Group, Department of Biological Sciences, University of North Texas, Denton, TX 76205, USA

Kenny Hansson

Bioscience Cardiovascular, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg 431 50, Sweden

Neha Iyer

Developmental Integrative Biology Research Group, Department of Biological Sciences, University of North Texas, Denton, TX 76205, USA

Pudur Jagadeeswaran

Developmental Integrative Biology Research Group, Department of Biological Sciences, University of North Texas, Denton, TX 76205, USA

Karin Jennbacken

Bioscience Cardiovascular, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg 431 50, Sweden

Katarina Rydén-Markinhutha

Bioscience Cardiovascular, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg 431 50, Sweden

Vishal Patel

Developmental Integrative Biology Research Group, Department of Biological Sciences, University of North Texas, Denton, TX 76205, USA

Revathi Raman

Developmental Integrative Biology Research Group, Department of Biological Sciences, University of North Texas, Denton, TX 76205, USA

Hersh Trivedi

Developmental Integrative Biology Research Group, Department of Biological Sciences, University of North Texas, Denton, TX 76205, USA

Karem Vazquez Roman

Developmental Integrative Biology Research Group, Department of Biological Sciences, University of North Texas, Denton, TX 76205, USA

Steven Williams

Developmental Integrative Biology Research Group, Department of Biological Sciences, University of North Texas, Denton, TX 76205, USA

Qing-Dong Wang

Bioscience Cardiovascular, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg 431 50, Sweden